IL10 and primary cutaneous T-cell non-Hodgkin lymphoma: In this way, tolerogenic DC induces T-cell anergy and induction of tolerogenic cytokines (IL-10), i.e., a phenotype resembling that of DC in cutaneous T-cell lymphoma (CTCL) [62].